Primiano Christopher Brett

CIK 00016035102 companiesNATICK, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001603510

Recent Transactions

50 trades

Award
Aura Biosciences, Inc.$AURA
Common Stock
2021-10-28+8,750→ 8,750 total
Award
Aura Biosciences, Inc.$AURA
Stock Option (Right to Buy)
2021-10-28+37,500→ 37,500 total
Exercise/Conversion
Karyopharm Therapeutics Inc.$KPTI
Stock Option (right to buy)
2020-12-01−78,124→ 46,876 total
Exercise/Conversion
Karyopharm Therapeutics Inc.$KPTI
Stock Option (right to buy)
2020-12-01−58,937→ 16,842 total
Sale
Karyopharm Therapeutics Inc.$KPTI
Common Stock
2020-12-01$17.66/sh−78,124→ 4,523 total
Exercise/Conversion
Karyopharm Therapeutics Inc.$KPTI
Common Stock
2020-12-01$10.39/sh+58,937→ 63,460 total
Sale
Karyopharm Therapeutics Inc.$KPTI
Common Stock
2020-12-01$17.35/sh−58,937→ 4,523 total
Exercise/Conversion
Karyopharm Therapeutics Inc.$KPTI
Common Stock
2020-12-01$10.45/sh+78,124→ 82,647 total
Sale
Karyopharm Therapeutics Inc.$KPTI
Common Stock
2020-11-02$14.92/sh−772→ 4,523 total
Exercise/Conversion
Karyopharm Therapeutics Inc.$KPTI
Common Stock
2020-10-13$10.39/sh+721→ 5,370 total
Exercise/Conversion
Karyopharm Therapeutics Inc.$KPTI
Stock Option (right to buy)
2020-10-13−38,550→ 64,250 total
Exercise/Conversion
Karyopharm Therapeutics Inc.$KPTI
Stock Option (right to buy)
2020-10-13−721→ 75,779 total
Exercise/Conversion
Karyopharm Therapeutics Inc.$KPTI
Common Stock
2020-10-13$9.21/sh+38,550→ 43,199 total
Sale
Karyopharm Therapeutics Inc.$KPTI
Common Stock
2020-10-13$17.20/sh−721→ 4,649 total
Sale
Karyopharm Therapeutics Inc.$KPTI
Common Stock
2020-10-13$16.85/sh−38,550→ 4,649 total
Exercise/Conversion
Karyopharm Therapeutics Inc.$KPTI
Stock Option (right to buy)
2020-09-08−10,054→ 0 total
Sale
Karyopharm Therapeutics Inc.$KPTI
Common Stock
2020-09-08$14.98/sh−10,054→ 4,649 total
Exercise/Conversion
Karyopharm Therapeutics Inc.$KPTI
Common Stock
2020-09-08$6.54/sh+10,054→ 14,703 total
Exercise/Conversion
Karyopharm Therapeutics Inc.$KPTI
Common Stock
2020-05-07$6.54/sh+2,946→ 7,595 total
Exercise/Conversion
Karyopharm Therapeutics Inc.$KPTI
Stock Option (right to buy)
2020-05-07−2,946→ 10,054 total
Sale
Karyopharm Therapeutics Inc.$KPTI
Common Stock
2020-05-07$19.62/sh−6,714→ 4,649 total
Sale
Karyopharm Therapeutics Inc.$KPTI
Common Stock
2020-05-07$20.00/sh−2,946→ 4,649 total
Sale
Karyopharm Therapeutics Inc.$KPTI
Common Stock
2020-03-02$24.00/sh−9,000→ 10,367 total
Exercise/Conversion
Karyopharm Therapeutics Inc.$KPTI
Stock Option (right to buy)
2020-03-02−26,500→ 76,500 total
Sale
Karyopharm Therapeutics Inc.$KPTI
Common Stock
2020-03-02$28.00/sh−10,000→ 19,367 total
Sale
Karyopharm Therapeutics Inc.$KPTI
Common Stock
2020-03-02$23.50/sh−7,500→ 29,367 total
Exercise/Conversion
Karyopharm Therapeutics Inc.$KPTI
Common Stock
2020-03-02$10.39/sh+26,500→ 36,867 total
Sale
Karyopharm Therapeutics Inc.$KPTI
Common Stock
2020-02-19$16.48/sh−2,961→ 10,367 total
Exercise/Conversion
Karyopharm Therapeutics Inc.$KPTI
Restricted Stock Units
2020-02-15−9,675→ 29,025 total
Exercise/Conversion
Karyopharm Therapeutics Inc.$KPTI
Common Stock
2020-02-15+9,675→ 13,328 total
Award
Karyopharm Therapeutics Inc.$KPTI
Restricted Stock Units
2020-02-05+30,300→ 30,300 total
Award
Karyopharm Therapeutics Inc.$KPTI
Stock Option (right to buy)
2020-02-05+81,200→ 81,200 total
Exercise/Conversion
Karyopharm Therapeutics Inc.$KPTI
Stock Option (right to buy)
2019-12-27−5,000→ 103,000 total
Sale
Karyopharm Therapeutics Inc.$KPTI
Common Stock
2019-12-27$20.00/sh−5,000→ 3,653 total
Exercise/Conversion
Karyopharm Therapeutics Inc.$KPTI
Common Stock
2019-12-27$10.39/sh+5,000→ 8,653 total
Sale
Karyopharm Therapeutics Inc.$KPTI
Common Stock
2019-12-06$17.46/sh−3,000→ 3,653 total
Exercise/Conversion
Karyopharm Therapeutics Inc.$KPTI
Common Stock
2019-12-06$6.54/sh+5,000→ 11,653 total
Exercise/Conversion
Karyopharm Therapeutics Inc.$KPTI
Common Stock
2019-12-06$10.39/sh+5,000→ 16,653 total
Sale
Karyopharm Therapeutics Inc.$KPTI
Common Stock
2019-12-06$17.45/sh−5,000→ 6,653 total
Exercise/Conversion
Karyopharm Therapeutics Inc.$KPTI
Stock Option (right to buy)
2019-12-06−5,000→ 108,000 total
Sale
Karyopharm Therapeutics Inc.$KPTI
Common Stock
2019-12-06$17.46/sh−5,000→ 11,653 total
Exercise/Conversion
Karyopharm Therapeutics Inc.$KPTI
Stock Option (right to buy)
2019-12-06−5,000→ 13,000 total
Award
Karyopharm Therapeutics Inc.$KPTI
Stock Option (right to buy)
2019-02-15+102,800→ 102,800 total
Award
Karyopharm Therapeutics Inc.$KPTI
Restricted Stock Units
2019-02-15+38,700→ 38,700 total
Sale
Karyopharm Therapeutics Inc.$KPTI
Common Stock
2018-09-10$18.90/sh−10,000→ 2,881 total
Exercise/Conversion
Karyopharm Therapeutics Inc.$KPTI
Stock Option (right to buy)
2018-09-10−5,000→ 18,000 total
Exercise/Conversion
Karyopharm Therapeutics Inc.$KPTI
Common Stock
2018-09-10$6.54/sh+5,000→ 7,881 total
Exercise/Conversion
Karyopharm Therapeutics Inc.$KPTI
Common Stock
2018-09-10$10.39/sh+5,000→ 12,881 total
Exercise/Conversion
Karyopharm Therapeutics Inc.$KPTI
Stock Option (right to buy)
2018-09-10−5,000→ 113,000 total
Sale
Karyopharm Therapeutics Inc.$KPTI
Common Stock
2018-05-10$18.01/sh−2,000→ 2,881 total

Companies

Recent Filings

Address

C/O KARYOPHARM THERAPEUTICS INC. 2 MERCER ROAD

NATICK, MA, 01760

View on SEC.gov